- Home
- VRCA vs CLPR Comparison
VRCA vs CLPR Comparison
Compare VRCA & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRCA | CLPR |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 54.6M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | VRCA | CLPR |
|---|---|---|
| Price | $8.60 | $3.45 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 402.7K | 70.1K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 11.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $30,829,000.00 | ★ $154,179,000.00 |
| Revenue This Year | $373.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 234.73 | 5.90 |
| 52 Week Low | $3.28 | $3.37 |
| 52 Week High | $9.82 | $6.49 |
Technical Indicators
Market Signals| Indicator | VRCA | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 65.02 | 41.85 |
| Support Level | $7.06 | $3.39 |
| Resistance Level | $9.78 | $3.50 |
| Average True Range (ATR) | 1.29 | 0.11 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 71.74 | 19.05 |
Price Performance
Historical ComparisonAbout VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.